Texas
|
59-2219994
|
(State
or other jurisdiction of
incorporation or
organization)
|
(I.R.S.
Employer Identification No.)
|
|
|
1200
Summit Ave., Suite 414
Fort
Worth, Texas
(Address of
Principal Executive Offices)
|
76102
(Zip
Code)
|
Large accelerated
filer ☐
|
Accelerated
filer ☐
|
|
Smaller reporting
company ☑
|
Non-accelerated
filer ☑
|
Emerging growth
company ☐
|
Exhibit No.
|
|
Description of Document
|
|
|
|
|
Certificate of Formation of Sanara MedTech Inc. (incorporated by
reference to Exhibit 3.1 to the Registrant’s Registration
Statement on Form S-1 filed with the SEC on April 11,
2008).
|
|
|
Amendment to Certificate of Formation of Sanara MedTech Inc.
(incorporated by reference to Exhibit A to the Registrant’s
Information Statement filed with the SEC on May 13,
2008).
|
|
|
Amendment to Certificate of Formation of Sanara MedTech Inc. of the
Certificate of Designations of the Series F Convertible Preferred
Stock (incorporated by reference to Exhibit 4.1 to the
Registrant’s Current Report on Form 8-K, filed with the SEC
on March 21, 2019).
|
|
4.4*
|
|
Amendments to Certificate of Formation of Sanara MedTech Inc. (i)
to increase the authorized common stock (April 20, 2015) and (ii)
to recapitalize the authorized capital stock and implement a
reverse stock split (May 3, 2019).
|
|
Bylaws of Sanara MedTech Inc. (incorporated by reference to Exhibit
3.2 to the Registrant’s Registration Statement on Form S-1
filed with the SEC on April 11, 2008).
|
|
|
Sanara MedTech Inc. Restated 2014 Omnibus Long Term Incentive Plan
(incorporated by reference to Exhibit A to the Registrant’s
Definitive Proxy Statement on Schedule 14A filed with the SEC on
June 25, 2020).
|
|
5.1*
|
|
Opinion of Kelly Hart & Hallman LLP regarding legality of
issued shares of common stock.
|
23.1*
|
|
Consent of Kelly Hart & Hallman LLP.
|
23.2*
|
|
Consent of MaloneBailey LLP, independent registered public
accounting firm.
|
|
Consent
of MaloneBailey LLP, independent registered public accounting
firm.
|
|
|
Power
of Attorney (set forth on the signature page of the Registration
Statement on Form S-8 filed with the SEC on February 21,
2020).
|
|
SANARA
MEDTECH INC.
(Registrant)
|
|
|
|
|
|
|
Date: November 16,
2020
|
By:
|
/s/ J. Michael
Carmena
|
|
|
|
J. Michael
Carmena
|
|
|
|
Vice Chairman and
Principal Executive Officer
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
*
Ronald
T. Nixon
|
|
Executive Chairman of the Board
|
November
16, 2020
|
|
|
|
|
|
|
/s/ J. Michael Carmena
J.
Michael Carmena
|
|
Vice Chairman of the Board
(Principal Executive Officer)
|
|
November
16, 2020
|
|
|
|
|
|
/s/ Robert A.
DeSutter
Robert
A. DeSutter
|
|
Director
|
|
November 16, 2020
|
|
|
|
|
|
*
Ann
Beal Salamone
|
|
Director
|
|
November
16, 2020
|
|
|
|
|
|
*
James
W. Stuckert
|
|
Director
|
|
November
16, 2020
|
|
|
|
|
|
*
Kenneth
E. Thorpe
|
|
Director
|
|
November 16, 2020
|
|
|
|
|
|
/s/ Michael D. McNeil
Michael D. McNeil
|
|
Chief Financial Officer
(Principal Financial Officer and Principal Accounting
Officer)
|
|
November 16, 2020
|